First-Time Clinical Trial Outcomes Show Promising Follow-Up Results HANGZHOU, China, June 19, 2023 /PRNewswire/ — On May 17th, the 12-month results of the DRAGONFLY-DMR pivotal trial were presented at EuroPCR 2023. This trial was led by Professor Jian’an Wang from Zhe’er Hospital, Hangzhou, China, and presented on his behalf by the Eligibility Committee Chair, Professor … Read more
HEFEI, China, 17. Juni 2023 /PRNewswire/ — TG ImmunoPharma Co., Ltd. (TGI), ein führendes Biotech-Unternehmen, das sich auf die Entwicklung neuartiger immunonkologischer Therapien spezialisiert hat, freut sich, bekannt zu geben, dass die FDA die Genehmigung der klinische Studie des TGI-6, seinem bahnbrechenden bispezifischen Antikörper, erteilt hat. TGI-6 zielt auf einzigartige tumorassoziierte Antigene (TAA) und gleichzeitig … Read more
HEFEI, China, June 16, 2023 /PRNewswire/ — TG ImmunoPharma Co., Ltd. (TGI), a leading biotech company focused on the development of novel immuno-oncology therapies, is pleased to announce that the FDA has granted clearance for the clinical trial of TGI-6, its groundbreaking bispecific antibody. TGI-6 targets unique tumor-associated antigens (TAA) and CD3 molecules simultaneously, enabling … Read more
HEFEI, China, June 16, 2023 /PRNewswire/ — TG ImmunoPharma Co., Ltd. (TGI), a leading biotech company focused on the development of novel immuno-oncology therapies, is pleased to announce that the FDA has granted clearance for the clinical trial of TGI-6, its groundbreaking bispecific antibody. TGI-6 targets unique tumor-associated antigens (TAA) and CD3 molecules simultaneously, enabling … Read more
Poster on FP-020, a follow-on, best-in-class, oral MMP-12 inhibitor in a genetic model of sarcoidosis includes efficacy, biomarkers and complete translational cellular profiling supporting novel anti-inflammatory and anti-fibrotic mechanism TAIPEI, June 16, 2023 /PRNewswire/ — Foresee Pharmaceuticals (6576.TWO), (“Foresee”) announced today that the company will be participating and presenting a poster at the WASOG 2023 … Read more
STOCKHOLM, June 14, 2023 /PRNewswire/ — MGI, a company committed to building core tools and technology to lead life science, announced the signing of a licensing agreement with Xpress Genomics, a leading Stockholm-based company specializing in automated and scalable RNA-sequencing strategies. This strategic collaboration aims to revolutionize the field of genomics through the development of … Read more
WUHAN, China, June 14, 2023 /PRNewswire/ — On June 9, 2023, the Synthetic Biology Technology Development Summit was held in Wuhan Optics Valley. The Summit was hosted by China Biotech Fermentation Industry Association and jointly undertaken by CABIO Biotech (Wuhan) Co., Ltd., Hubei Society for Microbiology and Wuhan Society for Microbiology. Yan Xingchun, Director of … Read more
NAN-ČCHANG, Čína, 12. júna 2023 /PRNewswire/ — Od 28. do 30. mája 2023 v čínskom Nan-čchangu úspešne prebehli 20. ročník veľtrhu China Association of Clinical Laboratory Practice Expo (CACLP) a 3. ročník veľtrhu China IVD Supply Chain Expo (CISCE), uznávané ako popredná svetová výstava diagnostiky in vitro (IVD). PR1 Na podujatí s výstavnou plochou 130 … Read more
NANCHANG, China, 12. Juni 2023 /PRNewswire/ — Vom 28. bis 30. Mai 2023, fand die 20. China Association of Clinical Laboratory Practice Expo (CACLP) und die 3. China IVD Supply Chain Expo (CISCE), die als die weltweit führende In-Vitro-Diagnosemesse (IVD) angesehen wird, in Nanchang, China, statt. PR1 Mit einer Ausstellungsfläche von 130.000 m², über 1.300 … Read more
NANCHANG, China, 12 de junio de 2023 /PRNewswire/ — Del 28 al 30 de mayo de 2023, se clausuraron con éxito en Nanchang, China, la 20ª Exposición de la Asociación China de Prácticas de Laboratorio Clínico (CACLP) y la 3ª Exposición de la Cadena de Suministro de IVD de China (CISCE), reconocidas como la principal … Read more